Autopsy report · NCT03348163

(mo)BETTA Trial in Transwomen for Optimization of ART

“Lack of ability to recruit due to COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 26 participants enrolled.
• Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

The University of Texas Health Science Center, Houston

Sponsor type

University, hospital or other

Conditions

HIV Infections

Interventions

B/FTC/TAF; Current ART

Participants

26

Sites

1

Countries

United States

Trials that died the same way

• Evaluating MyPath to Enhance Reproductive Autonomy and Liberate Decision-making
  “Recruitment hindered by COVID-19 pandemic, unable to recruit participants virtually” (88% match in meaning)
• Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
  “Inability to recruit during COVID” (88% match in meaning)
• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (88% match in meaning)
• Nocturnal Nasal Continuous Positive Airway Pressure in Aspiration Pneumonia
  “Hard to recruit due to COVID-19 issue.” (88% match in meaning)
• ANTERO-5: Gastric Motility in Postoperative Ileus
  “Inadequate recruitment due to COVID-19 restrictions.” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.